To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Roughly five years ago, Waukesha-based Kinex Medical ...

BUFFALO, N.Y., Feb. 5, 2014 /PRNewswire/ -- Kinex Pharmaceuticals, (Kinex), a leading specialty biotech focused on the development and commercialization of next generation oral therapies for cancer ...

Kinex Pharmaceutical and a Seneca Nation businessman are among half a dozen applicants from Western New York vying for a state license for medical marijuana. Kinex Pharmaceuticals LLC is hoping to add ...

Kinex Pharmaceuticals announced today that the first actinic keratosis patient has been dosed with KX2-391 ointment in Austin, Texas. KX2-391 (KX01), a dual Src/pre-tubulin inhibitor, is a small ...

“We can’t be spending all this money that we have with the Buffalo Billion, and everything that’s happened with the Medical Campus, to watch companies get to a certain point and then leave the region, ...